 BEIJING--BUSINESS WIRE--Sinovac Biotech Ltd. NASDAQ: SVA Sinovac or the Company, a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the third quarter ended September 30, 2020. Third Quarter and Nine Months Ended 2020 Financial Summary Sales for the third quarter of 2020 were 115.5 million, an increase of 79.4 from 64.3 million in the prior year period. Sales for the nine months ended September 30, 2020, were 183.2 million 